Monopar Therapeutics
MNPR
#7832
Rank
NZ$0.41 B
Marketcap
$68.11
Share price
-0.88%
Change (1 day)
1,146.45%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2023 (TTM): -$1.26

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.30. In 2022 the company made an earnings per share (EPS) of -$1.40 a decrease over its 2021 EPS that were of -$1.25.

EPS history for Monopar Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.26-9.85%
2022-$1.4012.16%
2021-$1.2527.59%
2020-$0.9843.71%
2019-$0.6833.52%
2018-$0.51-80.97%
2017-$2.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.67 183.12%๐Ÿ‡บ๐Ÿ‡ธ USA